Compass


09/07/20 -"Taking into account the recent trading update of one of Compass's major rivals, we are convinced that the health crisis may not have such a severe impact in the near term and that a recovery may take ..."

Pages
47
Language
English
Published on
09/07/20
You may also be interested by these reports :
07/08/20
The French hotel giant reported weaker-than-expected H1 results. Management expects that RevPAR will return to its normal level only by 2022 and ...

06/08/20
William Hill reported strong H1 20 numbers, with revenue and profits ahead of estimates. Revenue was down 32%, a significant improvement vs the 57% ...

30/07/20
The catering industry leader reported a mediocre Q3 trading performance but, fortunately, there was an improvement in the drop-through.

30/07/20
FDJ H1 20 numbers trumped estimates. Stakes came in at €6.9bn (-18%) with revenue at €849m (-14.7%). Though the decline was expected, the recovery in ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO